Journal of Medicinal Chemistry
Article
(6) Nordmann, P.; Poirel, L.; Lagrutta, E.; Taylor, P.; Pham, J.
Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-
Resistant Escherichia coli in Australia. Antimicrob. Agents Chemother.
2010, 54, 4914−4916.
(7) Talbot, G. H.; Bradley, J.; Edwards, J. E.; Gilbert, D.; Scheld, M.;
Bartlett, J. G. Bad Bugs Need Drugs: An Update on the Development
Pipeline from the Antimicrobial Availability Task Force of the
Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 42,
657−668.
(8) Paterson, D. L. Resistance in Gram-negative bacteria: Enter-
obacteriaceae. Am. J. Infect. Control 2006, 34, S20−S28 discussion S64−
S73.
(9) Zasloff, M. Antimicrobial peptides of multicellular organisms.
Nature 2002, 415, 389−395.
(10) Hancock, R. E.; Sahl, H. G. Antimicrobial and host−defense
peptides as new anti-infective therapeutic strategies. Nature Biotechnol.
2006, 24, 1551−1557.
(11) Rotem, S.; Mor, A. Antimicrobial peptide mimics for improved
therapeutic properties. Biochim. Biophys. Acta, Biomembr. 2009, 1788,
1582−1592.
(12) Hamuro, Y.; Schneider, J. P.; DeGrado, W. F. De Novo Design
of Antibacterial β-Peptides. J. Am. Chem. Soc. 1999, 121, 12200−
12201.
(13) Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H.
Efficient method for the preparation of peptoids [oligo(N-substituted
glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc.
1992, 114, 10646−10647.
(14) Hamper, B. C.; Kolodziej, S. A.; Scates, A. M.; Smith, R. G.;
Cortez, E. Solid Phase Synthesis of β-Peptoids: N-Substituted β-
Aminopropionic Acid Oligomers. J. Org. Chem. 1998, 63, 708−718.
(15) Schmitt, M. A.; Weisblum, B.; Gellman, S. H. Interplay among
folding, sequence, and lipophilicity in the antibacterial and hemolytic
activities of α/β-peptides. J. Am. Chem. Soc. 2007, 129, 417−428.
(16) Ryge, T. S.; Frimodt-Møller, N.; Hansen, P. R. Antimicrobial
activities of twenty lysine-peptoid hybrids against clinically relevant
bacteria and fungi. Chemotherapy 2008, 54, 152−6.
(17) Chongsiriwatana, N. P.; Patch, J. A.; Czyzewski, A. M.; Dohm,
M. T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R. N.; Barron, A. E.
Peptoids that mimic the structure, function, and mechanism of helical
antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 2794−
2799.
(18) Olsen, C. A.; Ziegler, H. L.; Nielsen, H. M.; Frimodt-Møller, N.;
Jaroszewski, J. W.; Franzyk, H. Antimicrobial, hemolytic, and cytotoxic
activities of β-peptoid-peptide hybrid oligomers: improved properties
compared to natural AMPs. ChemBioChem 2010, 11, 1356−60.
(19) Olsen, C. A.; Bonke, G.; Vedel, L.; Adsersen, A.; Witt, M.;
Franzyk, H.; Jaroszewski, J. W. α-Peptide/β-peptoid chimeras. Org.
Lett. 2007, 9, 1549−1552.
cell cargo delivery. Biochim. Biophys. Acta, Biomembr. 2010, 1798,
2201−2208.
(26) Godballe, T.; Nilsson, L. L.; Petersen, P. D.; Jenssen, H.
Antimicrobial β-Peptides and α-Peptoids. Chem. Biol. Drug. Des. 2011,
77, 107−116.
(27) ECDC. Annual Epidemiological Report 2011; European Centre
for Disease Control and Prevention: Stockholm, 2011.
(28) ECDC. Updated Risk Assessment on the Spread of NDM and Its
Variants within Europe; European Centre for Disease Prevention and
Control: Stockholm, 2011.
(29) Jenssen, H.; Hamill, P.; Hancock, R. E. W. Peptide
Antimicrobial Agents. Clin. Microbiol. Rev. 2006, 19, 491−511.
(30) Wu, C. W.; Sanborn, T. J.; Huang, K.; Zuckermann, R. N.;
Barron, A. E. Peptoid Oligomers with α-Chiral, Aromatic Side Chains:
Sequence Requirements for the Formation of Stable Peptoid Helices. J.
Am. Chem. Soc. 2001, 123, 6778−6784.
(31) Wu, C. W.; Kirshenbaum, K.; Sanborn, T. J.; Patch, J. A.; Huang,
K.; Dill, K. A.; Zuckermann, R. N.; Barron, A. E. Structural and
Spectroscopic Studies of Peptoid Oligomers with α-Chiral Aliphatic
Side Chains. J. Am. Chem. Soc. 2003, 125, 13525−13530.
(32) Mowery, B. P.; Lee, S. E.; Kissounko, D. A.; Epand, R. F.;
Epand, R. M.; Weisblum, B.; Stahl, S. S.; Gellman, S. H. Mimicry of
antimicrobial host−defense peptides by random copolymers. J. Am.
Chem. Soc. 2007, 129, 15474−15476.
(33) Martinek, T. A.; Fulop, F. Side-chain control of β-peptide
̈
̈
secondary structures. Eur. J. Biochem. 2003, 270, 3657−3666.
(34) Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.;
Jewell, D. A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; Marlowe, C.
K. Peptoids: a modular approach to drug discovery. Proc. Natl. Acad.
Sci. U.S.A. 1992, 89, 9367−9371.
(35) Hansen, T.; Alst, T.; Havelkova, M.; Strøm, M. B. Antimicrobial
Activity of Small β-Peptidomimetics Based on the Pharmacophore
Model of Short Cationic Antimicrobial Peptides. J. Med. Chem. 2009,
53, 595−606.
(36) Chen, Y. X.; Mant, C. T.; Farmer, S. W.; Hancock, R. E. W.;
Vasil, M. L.; Hodges, R. S. Rational design of α-helical antimicrobial
peptides with enhanced activities and specificity/therapeutic index. J.
Biol. Chem. 2005, 280, 12316−12329.
(37) Zhu, W. L.; Song, Y. M.; Park, Y.; Park, K. H.; Yang, S. T.; Kim,
J. I.; Park, I. S.; Hahm, K. S.; Shin, S. Y. Substitution of the leucine
zipper sequence in melittin with peptoid residues affects self-
association, cell selectivity, and mode of action. Biochim. Biophys.
Acta, Biomembr. 2007, 1768, 1506−1517.
(38) Slaninova,
́
J.; Mlsova, T.;
̌
́ ̌ ̌
ova, L.; Fucik, V.; Cerovsky, V. Toxicity study
́
V.; Kroupova,
́
H.; Alan
́
, L.; Tumova,
́
̊
Monincova, L.; Borovick
́
̌
́
of antimicrobial peptides from wild bee venom and their analogs
toward mammalian normal and cancer cells. Peptides 2012, 33, 18−26.
(39) Mygind, P. H.; Fischer, R. L.; Schnorr, K. M.; Hansen, M. T.;
Sonksen, C. P.; Ludvigsen, S.; Raventos, D.; Buskov, S.; Christensen,
B.; De Maria, L.; Taboureau, O.; Yaver, D.; Elvig-Jorgensen, S. G.;
Sorensen, M. V.; Christensen, B. E.; Kjaerulff, S.; Frimodt-Møller, N.;
Lehrer, R. I.; Zasloff, M.; Kristensen, H.-H. Plectasin is a peptide
antibiotic with therapeutic potential from a saprophytic fungus. Nature
2005, 437, 975−980.
(20) Park, K. H.; Nan, Y. H.; Park, Y.; Kim, J. I.; Park, I. S.; Hahm, K.
S.; Shin, S. Y. Cell specificity, anti-inflammatory activity, and plausible
bactericidal mechanism of designed Trp-rich model antimicrobial
peptides. Biochim. Biophys. Acta, Biomembr. 2009, 1788, 1193−1203.
(21) Bonke, G.; Vedel, L.; Witt, M.; Jaroszewski, J. W.; Olsen, C. A.;
Franzyk, H. Dimeric building blocks for solid-phase synthesis of α-
peptide-β-peptoid chimeras. Synthesis 2008, 2381−2390.
(22) Kruijtzer, J. A. W.; Hofmeyer, L. J. F.; Heerma, W.; Versluis, C.;
Liskamp, R. M. J. Solid-phase syntheses of peptoids using Fmoc-
protected N-substituted glycines: The synthesis of (retro) peptoids of
Leu-enkephalin and substance P. Chem.Eur. J. 1998, 4, 1570−1580.
(40) Hope, M. J.; Bally, M. B.; Webb, G.; Cullis, P. R. Production of
Large Unilamellar Vesicles by a Rapid Extrusion Procedure
Characterization of Size Distribution, Trapped Volume and Ability
to Maintain a Membrane-Potential. Biochim. Biophys. Acta 1985, 812,
55−65.
(41) Foged, C.; Franzyk, H.; Bahrami, S.; Frokjaer, S.; Jaroszewski, J.
W.; Nielsen, H. M.; Olsen, C. A. Cellular uptake and membrane-
destabilising properties of α-peptide/β-peptoid chimeras: lessons for
the design of new cell-penetrating peptides. Biochim. Biophys. Acta,
Biomembr. 2008, 1778, 2487−2495.
(42) Greenfield, N. J. Using circular dichroism spectra to estimate
protein secondary structure. Nature Protoc. 2006, 1, 2876−2890.
(23) Noack, M.; Gottlich, R. Iodide-Catalysed Cyclization of
̈
Unsaturated N-Chloroamines: A New Way to Synthesise 3-
Chloropiperidines. Eur. J. Org. Chem. 2002, 2002, 3171−3178.
(24) Østergaard, S.; Holm, A. Peptomers: A Versatile Approach for
the Preparation of Diverse Combinatorial Peptidomimetic Bead
Libraries. Mol. Divers. 1997, 3, 17−27.
(25) Zhang, X. A.; Oglecka, K.; Sandgren, S.; Belting, M.; Esbjorner,
E. K.; Norden, B.; Graslund, A. Dual functions of the human
antimicrobial peptide LL-37-Target membrane perturbation and host
7261
dx.doi.org/10.1021/jm300820a | J. Med. Chem. 2012, 55, 7253−7261